By G HossainPosted on March 6, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Servier will pick up Ojemda, which received FDA approval in 2024 to treat pediatric glioma. The drug clocked sales of $155 million for Day One Biopharmaceuticals in 2025. Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy Post navigation Alltrna’s Clinical Acceleration Aims Leave 35% of Staff BehindOn the move: BDO named advisor for celebrity-led motorcycle team